1. Accelerated approval requirements for lurbinectedin. Issue 5 (May 2022) Authors: Benjamin, David J; Prasad, Vinay Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: e206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: a population-based study. (9th November 2020) Authors: Abrahão, Renata; Huynh, Jasmine C; Benjamin, David J; Li, Qian W; Winestone, Lena E; Muffly, Lori; Keegan, Theresa H M Journal: International journal of epidemiology Issue: Volume 50:Number 2(2021) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FDA decisions on new oncological drugs. Issue 5 (May 2022) Authors: Benjamin, David J; Prasad, Vinay; Lythgoe, Mark P Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma. (September 2022) Authors: Benjamin, David J; Mar, Nataliya; Rezazadeh Kalebasty, Arash Journal: Clinical medicine insights. Oncology Issue: Volume 16(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modernising the US FDA's Accelerated Approval pathway. Issue 3 (March 2023) Authors: Benjamin, David J; Lythgoe, Mark P Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. New and emerging therapies for acute myeloid leukaemia. (19th August 2018) Authors: Davis, Julian R; Benjamin, David J; Jonas, Brian A Journal: Journal of investigative medicine Issue: Volume 66:Number 8(2018) Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. New and emerging therapies for acute myeloid leukaemia. (December 2018) Authors: Davis, Julian R; Benjamin, David J; Jonas, Brian A Journal: Journal of investigative medicine Issue: Volume 66:Number 8(2018) Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PI3K inhibitors in haematological malignancies. Issue 8 (August 2022) Authors: Benjamin, David J; Prasad, Vinay Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: e362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗